LFCR Lifecore: Net earnings per share for the last four quarters

Lifecore Biomedical Inc. (LFCR) - corporate logo

The visual price representation available on the GURU.Markets platform demonstrates the EPS (TTM) dynamics for Lifecore Biomedical (LFCR), which currently stands at -432.10. The Lifecore Biomedical (LFCR) business relies on the implementation of AI and robotics in biopharmaceutical production to reduce costs. While geopolitical conflicts and sanctions hinder the international import of raw materials, the company's unique sterile injectable manufacturing capacities protect Lifecore Biomedical (LFCR) from aggressive pricing pressure from competitors.

LFCR (Lifecore Biomedical Inc.) Earnings per share for the last twelve months history from 02/11/2024 to 11/13/2026

Lifecore - analytical breakdowns and key metrics (LFCR)

- price and consensus price forecast:
Market Price Lifecore Biomedical|LFCR - Price Target Chart
- company stock capitalization data:
Market Capitalization Lifecore Biomedical Inc.|LFCR - Real Price to Acquire Entire Company
- book value of equity indicators:
Book Price of a Share Lifecore Biomedical|LFCR - Company Book Value|Market Capitalization to Book Value lifecore.com|LFCR - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Lifecore Biomedical|LFCR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Lifecore Biomedical|LFCR - Company Aggregate Debts|Debts to Book Capitalization Ratio Lifecore Biomedical Inc.|LFCR - Company Long-Term Debts|Short-Term Debt Lifecore Biomedical|Quick Liquidity Indicator lifecore.com
- net income and valuation multiples indicators:
LFCR - Company Net Income|Expected Net Profit Lifecore Biomedical|LFCR - Price to Earnings Ratio|Future Price to Earnings Multiple Lifecore Biomedical|LFCR - PEG Multiple|Company Value to EBITDA Lifecore Biomedical Inc.|LFCR - Operating profit before deduction of amortization|Earnings per share for the trailing year Lifecore Biomedical|LFCR - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months lifecore.com|LFCR - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Lifecore Biomedical
Fundamental company valuation:Lifecore Biomedical, Inc.
Flagship merchandise of Lifecore Biomedical, Inc.

For Lifecore Biomedical (LFCR), this indicator reflects the monetization efficiency of its unique CDMO capacities within the injectables segment. The 12-month EPS annual growth rate is calculated as the percentage change in earnings per share over the last four quarters relative to the same period last year. The growth of this metric confirms the company's ability to convert strict FDA standards into financial results. The stability of this figure underscores the high switching costs for customers moving to other manufacturers.

Competitor analysis for Lifecore Biomedical

Net earnings per one share for the last twelve months iqvia.com|Labcorp (LH) - Earnings per share for the last twelve months|MEDP - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ICLR|CRL (Charles River Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Evotec SE (EVO)|Net earnings per share for the last four quarters fortrea.com|Earnings per share for the last twelve months OmniAb OABI|Inotiv Inc - Earnings per share for the last twelve months|Avid Bioservices, Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Catalent, Inc CTLT|SCPX: Net earnings per share (EPS TTM)